Business Description
Sartorius Stedim Biotech SA
ISIN : FR0013154002
Description
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.03 | |||||
Equity-to-Asset | 0.34 | |||||
Debt-to-Equity | 1.4 | |||||
Debt-to-EBITDA | 4.8 | |||||
Interest Coverage | 3.68 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 3.49 | |||||
Beneish M-Score | -2.93 | |||||
WACC vs ROIC |
Growth Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 13.3 | |||||
3-Year EBITDA Growth Rate | 9.9 | |||||
3-Year EPS without NRI Growth Rate | -9.9 | |||||
3-Year FCF Growth Rate | 1.9 | |||||
3-Year Book Growth Rate | 22.4 | |||||
Future 3-5Y EPS without NRI Growth Rate | 15.1 | |||||
Future 3-5Y Total Revenue Growth Rate | 12.1 |
Momentum Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 24.25 | |||||
9-Day RSI | 24.46 | |||||
14-Day RSI | 27.31 | |||||
6-1 Month Momentum % | 42.56 | |||||
12-1 Month Momentum % | 5.32 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.51 | |||||
Quick Ratio | 0.57 | |||||
Cash Ratio | 0.12 | |||||
Days Inventory | 236.38 | |||||
Days Sales Outstanding | 44.45 | |||||
Days Payable | 85.91 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 0.33 | |||||
Dividend Payout Ratio | 0.43 | |||||
3-Year Dividend Growth Rate | 61.8 | |||||
Forward Dividend Yield % | 0.33 | |||||
5-Year Yield-on-Cost % | 1.16 | |||||
Shareholder Yield % | -7.67 |
Profitability Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 44.44 | |||||
Operating Margin % | 16.95 | |||||
Net Margin % | 11.16 | |||||
FCF Margin % | 9.83 | |||||
ROE % | 12.22 | |||||
ROA % | 4.99 | |||||
ROIC % | 6.61 | |||||
ROC (Joel Greenblatt) % | 26.39 | |||||
ROCE % | 10.11 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 61.99 | |||||
Forward PE Ratio | 35.09 | |||||
PE Ratio without NRI | 61.99 | |||||
Shiller PE Ratio | 58.21 | |||||
Price-to-Owner-Earnings | 40.36 | |||||
PEG Ratio | 2.47 | |||||
PS Ratio | 6.91 | |||||
PB Ratio | 7.28 | |||||
Price-to-Free-Cash-Flow | 70.42 | |||||
Price-to-Operating-Cash-Flow | 25.71 | |||||
EV-to-EBIT | 45.08 | |||||
EV-to-Forward-EBIT | 37.19 | |||||
EV-to-EBITDA | 31.1 | |||||
EV-to-Forward-EBITDA | 28.19 | |||||
EV-to-Revenue | 8.59 | |||||
EV-to-Forward-Revenue | 8.18 | |||||
EV-to-FCF | 87.38 | |||||
Price-to-Projected-FCF | 3.67 | |||||
Price-to-DCF (Earnings Based) | 1.63 | |||||
Price-to-DCF (FCF Based) | 1.91 | |||||
Price-to-Median-PS-Value | 0.52 | |||||
Price-to-Peter-Lynch-Fair-Value | 2.48 | |||||
Earnings Yield (Greenblatt) % | 2.22 | |||||
FCF Yield % | 1.35 | |||||
Forward Rate of Return (Yacktman) % | 21.27 |